Professor Peter Schmid, FRCP, MD, PhD, Leisha A. Emens, MD, PhD, and Heather L. McArthur, MD, MPH, discuss the expanding role of immunotherapy in triple-negative breast cancer in this CME/MOC/CNE activity titled, "On the Cusp of the Era of Immuno-Oncology in Triple-Negative Breast Cancer: Rational Strategies to Make the Most of Immunotherapies and Other Effective Treatment Modalities Throughout the Disease Continuum." For the full presentation, downloadable practice aids, monograph, complete CME/MOC/CNE information, and to apply for credit, please visit us at http://bit.ly/34aGu95. CME/MOC/CNE credit will be available until December 29, 2020.